Kiromic Biopharma

General Information


We are a target discovery and gene editing company utilizing artificial intelligence and our proprietary neural network platform with a therapeutic focus on immuno-oncology. Our proprietary target discovery engine is called “Diamond.”

Diamond is a computational platform and a neural network that can identify new cancer immunological targets for T cells and B cells. Diamond is an artificial intelligence bioinformatic approach that can identify novel surface tumor targets. It uses public and proprietary samples and can expand into the tumor target space.

Employees: 11
Founded: 2006
Contact Information
Address 7707 Fannin, Suite 140, Houston, TX 77054, US
Phone Number (832) 968-4888
Web Address
View Prospectus: Kiromic Biopharma
Financial Information
Market Cap $94.1mil
Revenues $0 mil (last 12 months)
Net Income $-3.73 mil (last 12 months)
IPO Profile
Symbol KRBP
Exchange NASDAQ
Shares (millions): 1.3
Price range $12.00 - $12.00
Est. $ Volume $15.0 mil
Manager / Joint Managers ThinkEquity
CO-Managers Paulson Investment Company
Expected To Trade: 10/16/2020
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change